{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:51:52Z","timestamp":1782467512080,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115363"],"award-info":[{"award-number":["115363"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001734","name":"K\u00f8benhavns Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovationsfonden","doi-asserted-by":"publisher","award":["5150-00024B"],"award-info":[{"award-number":["5150-00024B"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ejps.2020.105272","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T22:45:56Z","timestamp":1582065956000},"page":"105272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Evaluation of self-emulsifying drug delivery systems for oral insulin delivery using an in vitro model simulating the intestinal proteolysis"],"prefix":"10.1016","volume":"147","author":[{"given":"Jingying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2489-1392","authenticated-orcid":false,"given":"Cosima","family":"Hirschberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Fan\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9246-3931","authenticated-orcid":false,"given":"Huiling","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3020-8892","authenticated-orcid":false,"given":"Anette","family":"M\u00fcllertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2020.105272_bib0001","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3109\/03639045.2014.886695","article-title":"Formulation of solid self-nanoemulsifying drug delivery systems using N-methyl pyrrolidone as cosolvent","volume":"41","author":"Agrawal","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2020.105272_bib0002","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijpharm.2018.10.066","article-title":"Application of in vitro lipolysis for the development of oral self-emulsified delivery system of Nimodipine","volume":"553","author":"Alayoubi","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105272_bib0003","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijpharm.2009.03.008","article-title":"Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems","volume":"374","author":"Balakrishnan","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105272_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(97)00204-6","article-title":"The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins","volume":"52","author":"Bernkop-Schn\u00fcrch","year":"1998","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2020.105272_bib0005","article-title":"Do drug release studies from SEDDS make any sense?","author":"Bernkop-Schn\u00fcrch","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2020.105272_bib0006","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ijpharm.2016.07.016","article-title":"Development and evaluation of viscosity-enhanced nanocarrier (VEN) for oral insulin delivery","volume":"511","author":"Boushra","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105272_bib0007","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2009.10.005","article-title":"Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics","volume":"142","author":"Buyukozturk","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2020.105272_bib0008","doi-asserted-by":"crossref","first-page":"9826","DOI":"10.1016\/j.biomaterials.2011.08.087","article-title":"A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery","volume":"32","author":"Chen","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2020.105272_bib0009","series-title":"Zeta Potential Measurement, Characterization of Nanoparticles Intended for Drug Delivery","first-page":"63","author":"Clogston","year":"2011"},{"key":"10.1016\/j.ejps.2020.105272_bib0010","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jconrel.2006.05.013","article-title":"Biodegradable nanoparticles loaded with insulin\u2013phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation","volume":"114","author":"Cui","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2020.105272_bib0011","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/10611860290022688","article-title":"Absorption enhancing effect of labrasol on the intestinal absorption of insulin in rats","volume":"10","author":"Eaimtrakarn","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejps.2020.105272_bib0012","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejpb.2009.06.004","article-title":"Formulation and characterization of an oily-based system for oral delivery of insulin","volume":"73","author":"Elsayed","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2020.105272_bib0013","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejps.2017.08.022","article-title":"Solid self-nanoemulsifying drug delivery systems for oral delivery of polypeptide-k: Formulation, optimization, in-vitro and in-vivo antidiabetic evaluation","volume":"109","author":"Garg","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105272_bib0014","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0003-9861(62)90253-9","article-title":"Adsorption and enzymic activity of chymotrypsin at an n-octadecane-water interface","volume":"99","author":"Ghosh","year":"1962","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejps.2020.105272_bib0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijpharm.2017.03.027","article-title":"Comparison of the protective effect of self-emulsifying peptide drug delivery systems towards intestinal proteases and glutathione","volume":"523","author":"Het\u00e9nyi","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105272_bib0016","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpharm.2014.05.047","article-title":"In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin","volume":"472","author":"Hintzen","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105272_bib0017","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0378-5173(94)00232-T","article-title":"Drug delivery studies in Caco-2 monolayers. II. Absorption enhancer effects of lysophosphatidylcholines","volume":"114","author":"Hovgaard","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105272_bib0018","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10895-015-1748-1","article-title":"Synthesis and identification of FITC-insulin conjugates produced using human insulin and insulin analogues for biomedical applications","volume":"26","author":"Jacob","year":"2016","journal-title":"J. Fluoresc."},{"key":"10.1016\/j.ejps.2020.105272_bib0019","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2020.105272_bib0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejpb.2015.04.013","article-title":"Effective incorporation of insulin in mucus permeating self-nanoemulsifying drug delivery systems","volume":"97","author":"Karamanidou","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2020.105272_bib0021","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3390\/pharmaceutics4040641","article-title":"SNEDDS containing poorly water soluble cinnarizine; development and in vitro characterization of dispersion, digestion and solubilization","volume":"4","author":"Larsen","year":"2012","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2020.105272_bib0022","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijpharm.2016.04.044","article-title":"Impact of lipases on the protective effect of SEDDS for incorporated peptide drugs towards intestinal peptidases","volume":"508","author":"Leonaviciute","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105272_bib0023","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1002\/jps.23640","article-title":"Preparation and characterization of insulin-surfactant complexes for loading into lipid\u2010based drug delivery systems","volume":"102","author":"Li","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105272_bib0024","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.xphs.2016.01.006","article-title":"Impact of lipid-based drug delivery systems on the transport and uptake of insulin across Caco-2 cell monolayers","volume":"105","author":"Li","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105272_bib0025","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijpharm.2014.10.039","article-title":"Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading","volume":"477","author":"Li","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105272_bib0026","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpharm.2017.04.058","article-title":"Inhibitory effect of emulsifiers in sedds on protease activity: just an illusion?","volume":"526","author":"Lupo","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105272_bib0027","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/j.1745-7254.2006.00424.x","article-title":"In vitro and in vivo evaluation of a novel oral insulin formulation","volume":"27","author":"Ma","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejps.2020.105272_bib0028","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jconrel.2019.08.008","article-title":"Labrasol\u00ae is an efficacious intestinal permeation enhancer across rat intestine: ex vivo and in vivo rat studies","volume":"310","author":"McCartney","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2020.105272_bib0029","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jconrel.2018.03.018","article-title":"In vivo evaluation of an oral self-emulsifying drug delivery system (SEDDS) for exenatide","volume":"277","author":"Menzel","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2020.105272_bib0030","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1039\/C3FO60702J","article-title":"A standardised static in vitro digestion method suitable for food\u2013an international consensus","volume":"5","author":"Minekus","year":"2014","journal-title":"Food Funct."},{"key":"10.1016\/j.ejps.2020.105272_bib0046","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.addr.2016.01.010","article-title":"Oral delivery of macromolecular drugs: Where we are after almost 100 years of attempts","volume":"101","author":"Moroz","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2020.105272_bib0031","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0378-5173(01)00595-6","article-title":"The effect of absorption enhancers on the initial degradation kinetics of insulin by alpha-chymotrypsin","volume":"217","author":"Radwan","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105272_bib0032","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ijpharm.2008.05.018","article-title":"Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: i. Formulation development","volume":"362","author":"Rao","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105272_bib0033","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ijbiomac.2013.08.002","article-title":"Combining two technologies: multifunctional polymers and self-nanoemulsifying drug delivery system (SNEDDS) for oral insulin administration","volume":"61","author":"Sakloetsakun","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejps.2020.105272_bib0034","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0378-5173(94)00386-J","article-title":"Using microemulsion formulations for oral-drug delivery of therapeutic peptides","volume":"120","author":"Sarciaux","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105272_bib0035","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1002\/adfm.201505252","article-title":"Thiolation and cell\u2010penetrating peptide surface functionalization of porous silicon nanoparticles for oral delivery of insulin","volume":"26","author":"Shrestha","year":"2016","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ejps.2020.105272_bib0036","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cis.2011.02.001","article-title":"Behaviour of protein-stabilised emulsions under various physiological conditions","volume":"165","author":"Singh","year":"2011","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.ejps.2020.105272_bib0037","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1002\/jps.21183","article-title":"Past, present, and future technologies for oral delivery of therapeutic proteins","volume":"97","author":"Singh","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105272_bib0038","series-title":"Introduction to Rheology, Rheological Methods in Food Process Engineering","first-page":"1","author":"Steffe","year":"1996"},{"key":"10.1016\/j.ejps.2020.105272_bib0039","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/jps.23054","article-title":"Influence of lipid composition and drug load on the in vitro performance of self\u2010nanoemulsifying drug delivery systems","volume":"101","author":"Thomas","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105272_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2017.03.393","article-title":"In vitro and in vivo performance of monoacyl phospholipid-based self-emulsifying drug delivery systems","author":"Tran","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2020.105272_bib0041","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijpharm.2016.02.026","article-title":"Formulation and characterization of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine","volume":"502","author":"Tran","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105272_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2017.07.008","article-title":"Review\u2013an update on the use of oral phospholipid excipients","volume":"108","author":"van Hoogevest","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105272_bib0043","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s11745-016-4203-4","article-title":"Sesame oil and rice bran oil ameliorates adjuvant-induced arthritis in rats: distinguishing the role of minor components and fatty acids","volume":"51","author":"Yadav","year":"2016","journal-title":"Lipids"},{"key":"10.1016\/j.ejps.2020.105272_bib0044","article-title":"Solid lipid nanoparticles modified with stearic acid\u2013octaarginine for oral administration of insulin","volume":"7","author":"Zhang","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2020.105272_bib0045","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.3109\/10717544.2016.1143056","article-title":"Development and in vitro evaluation of an oral SEDDS for desmopressin","volume":"23","author":"Zupan\u010di\u010d","year":"2016","journal-title":"Drug Delivery"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720300610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720300610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:55:35Z","timestamp":1778558135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098720300610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":46,"alternative-id":["S0928098720300610"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105272","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of self-emulsifying drug delivery systems for oral insulin delivery using an in vitro model simulating the intestinal proteolysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105272"}}